SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines

ConclusionsOur results indicate that lncRNA SNHG6 is involved in breast cancer development and may be considered as a potential biomarker for the diagnosis, prognosis and treatment of breast cancer.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research